NLS Parkinson's Disease

Finnish Biotie announces start of tozadenant Phase 3 Study of tozadenant, an investigational adenosine A2a receptor antagonist, in patients with Parkinson’s disease experiencing levodopa related end-of-dose “wearing-off”. The Phase 3 study (TOZ-PD) is a randomized, double-blind, placebo controlled trial that will evaluate efficacy and safety of tozadenant compared to placebo in 450 PD patients experiencing […]

A new study published in the journal Annals of Neurology suggests that the vagus nerve — which connects the brain with he abdominal tract — may transport Parkinson’s disease from the stomach up to the brain. If the nerve is severed early, the occurrence of Parkinson’s can be halved, the research shows. According to Elisabeth […]

A weak electric “noise” can adjust the balance and motor skills of patients with Parkinson’s disease, according to a study performed at Sahlgrenska Academy. Researchers working with NASA have developed a prototype of a portable electrical stimulation device that will be used in long-term studies of Parkinson’s patients in their homes. In a study involving 10 Swedish Parkinson’s patients, participants received an active […]

Parkinson’s disease sufferers have a different microbiota in their intestines than their healthy counterparts, according to a study conducted at the University of Helsinki and the Helsinki University Central Hospital. Researchers are now trying to determine what the connection between intestinal microbes and Parkinson’s disease is. “Our most important observation was that patients with Parkinson’s […]